Dr. Samuel Klempner | CureTalks
Dr. Samuel Klempner is a clinical and translational researcher at The Angeles Clinic in Los Angeles. His research is focused on experimental therapeutics in solid tumors - exploiting tumor genomic features to guide targeted therapies and combination immunotherapies. He is clinically focused on Esophagogastric cancers and oncogene-driven tumors. Dr. Klempner completed his residency in internal medicine at Brigham and Women’s Hospital/Harvard Medical School, followed by a combined hematology-oncology fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Klempner is board certified in medical oncology, hematology, and internal medicine. His research has been published in prestigious journals such as the Journal of Clinical Oncology (JCO), Cancer Discovery, JAMA Oncology, and Annals of Oncology.
Precision, or personalized, medicine has made a sea-change in cancer treatment. A pipe dream for most patients 10 years ago, it is a…